Binx Health
Total Raised
$203.5MInvestors Count
20Deal Terms
2Binx Health Funding, Binx Health Valuation & Binx Health Revenue
8 Fundings
Binx Health's latest funding round was a Series E for $104M on May 27, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/27/2021 | Series E | $104M | 2 | |||
11/10/2020 | Series D - II | |||||
1/23/2017 | Series D | |||||
1/29/2015 | Series C | |||||
4/29/2014 | Series B - II |
Date | 5/27/2021 | 11/10/2020 | 1/23/2017 | 1/29/2015 | 4/29/2014 |
|---|---|---|---|---|---|
Round | Series E | Series D - II | Series D | Series C | Series B - II |
Amount | $104M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 |
Binx Health Deal Terms
2 Deal Terms
Binx Health's deal structure is available for 2 funding rounds, including their Series B from July 20, 2011.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Binx Health Investors
20 Investors
Binx Health has 20 investors. Life Sciences Partners invested in Binx Health's Series E funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/20/2011 | 5/27/2021 | 5 Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021) | Venture Capital | Netherlands | ||
7/20/2011 | 5/27/2021 | 5 Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021) | Corporate Venture | New Jersey | ||
11/10/2020 | 5/27/2021 | 2 Series D - II, Series E (2021) | Venture Capital | Spain | ||
Asset/Investment Management | New York | |||||
Asset/Investment Management | Colorado |
First funding | 7/20/2011 | 7/20/2011 | 11/10/2020 | ||
|---|---|---|---|---|---|
Last Funding | 5/27/2021 | 5/27/2021 | 5/27/2021 | ||
Investor | |||||
Rounds | 5 Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021) | 5 Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021) | 2 Series D - II, Series E (2021) | ||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Venture Capital | Asset/Investment Management | Asset/Investment Management |
Location | Netherlands | New Jersey | Spain | New York | Colorado |